NCT04045405View on ClinicalTrials.gov

Clinical Study to Assess Safety, PK and PD Parameters of CDR132L

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

June 21, 2019

Primary Completion Date

January 31, 2020

Study Completion Date

June 26, 2020

Conditions
Heart Failure
Interventions
DRUG

CDR132L

i.v. administration

Trial Locations (1)

SE1 1YR

Richmond Pharmacology Ltd., 1A Newcomen Street, London Bridge, London

Sponsors
All Listed Sponsors
lead

Cardior Pharmaceuticals GmbH

INDUSTRY